Keywords: Whole Body, Cancer, Immunity therapyLow immune infiltrates severely hinder cancer immunotherapy. Hence, we developed a manganese-phenolic networks platform (TMPD) The TMPD was based on doxorubicin (DOX) loaded PEG-PLGA nanoparticles and further coated with manganese (Mn)-tannic acid (TA) networks. Mechanistically, DOX could kill cancer cells while Mn2+ could significantly increase the activity of STING pathway related protein to amplify the STING signal and has the function of MRI T1 imaging. The nanoplatform could promote the presentation of tumor antigens and activate a robust innate and adaptive immunity, providing reference for the application of molecular imaging in tumor diagnosis and treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords